Auna (AUNA) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
FY 2023 revenue rose 58.1% YoY to S/ 3,875.9 million, partly reflecting Grupo OCA; operating profit increased 120.1% to S/ 560.3 million, while net loss widened to S/ 214.3 million.
Operating cash flow increased to S/ 582.4 million from S/ 162.6 million; year-end cash and cash equivalents were S/ 241.1 million.
Financial highlights
Revenue from customer contracts rose 58.1% YoY to S/ 3,875.9 million; gross profit grew 63.2% to S/ 1,435.3 million.
Operating profit increased to S/ 560.3 million from S/ 254.6 million; net finance cost rose to S/ 690.8 million from S/ 305.8 million.
Net loss widened to S/ 214.3 million from S/ 76.8 million, despite higher operating profit, amid increased finance costs and income tax expense.
Outlook and guidance
Available cash, expected operating cash flows and revolving credit lines were expected to cover capital expenditure and liquidity needs for the foreseeable future.
Significant future strategic acquisitions could require additional debt or equity financing.
Latest events from Auna
- Revenue outlook holds; Colombian contract costs reset FY26 EBITDA expectations to stable YoY.AUNA
Investor Day 2026 - Revenue up 13% YoY, free cash flow up 181%, EBITDA down 6% YoY, 2026 growth guidance reaffirmed.AUNA
Q2 2026 - Revenue up 13% YoY, strong cash flow, margin down, guidance reaffirmed.AUNA
Q1 2026 - FY25 saw strong cash flow, Peru and Colombia growth, and a 12% FXN growth target for 2026.AUNA
Q4 2025 - Healthcare group targets $1B NYSE offering to expand Latin American operations.AUNA
Registration Filing - Healthcare group seeks up to $1B in NYSE-listed shares to fund growth in Latin America.AUNA
Registration Filing - Peru and Colombia drove growth, Mexico lagged; leverage stable, refinancing and recovery plans set.AUNA
Q3 2025 - Adjusted EBITDA up 23% YoY, leverage ratio at 3.7x, and OncoMexico pilot advancing.AUNA
Q3 2024 - Adjusted EBITDA up 31% YoY, revenue up 18% YoY, and leverage ratio improved to 4.13x.AUNA
Q2 2024